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The polycomb group transcriptional repressor Bmi-1 regulates both normal and cancer stem cells in multiple
tissues. In this issue of Cell Stem Cell, Lukacs et al. (2010) report that Bmi-1 also regulates the self-renewal of
at least one prostate stem cell population and is involved in prostate cancer initiation and progression.Most adult tissues harbor self-renewing
stem cells that are generally quiescent
(Fuchs, 2009). The prostate is a glandular
organ whose development is driven by
androgen. The ability of adult rodent pros-
tate to repeatedly involute and regenerate
as androgen is experimentally withdrawn
and replaced suggests the presence
of stem cells that weather androgen depri-
vation and repopulate the gland upon
androgen restoration. Mouse prostate
has four distinct lobes, i.e., anterior,
ventral, dorsal, and lateral. Within each
lobe are prostatic ducts that originate in
the region proximal to the urethra and
branch out into tree-like structures, termi-
nating intodistal tip regionsphysiologically
distinct from the proximal and interme-
diate regions (Figure 1A). Human prostate
differs in that it does not contain anatomi-
cally distinct lobes. Mouse prostatic
glands contain a single layer of luminal
secretory epithelial cells surrounded by
a layer of basal epithelial cells (Figure 1B).
In vitro clonal assays and in vivo tissue
regeneration using purified cell popula-
tions, in situ labeling, and lineage tracing
studies have revealed at least four popula-
tions of prostate stem cells in basal and/or
luminal compartments (Figure 1B). Early
studies using a BrdU (bromodeoxyuridine)
label-retaining approach to identify quies-
cent prostate stem cells revealed that the
long-term label-retaining cells, or LRCs,
are concentrated in the prostate tubules
proximal to the urethra and distributed
nearly equally in basal as well as luminal
layers within the proximal region (Tsuji-
mura et al., 2002), providing the first piece
of in vivo evidence that prostate epithelial
stem cells may exist in both basal and
luminal cell compartments.The slow-cycling stem cells in proximal
tubules (Figure 1A) were subsequently
found to be enriched in the Sca-1+ cell
population that also expresses high levels
of integrin a6 (CD49f) (Burger et al., 2005;
Xin et al., 2005). Further purifications
using combinatorial markers have identi-
fied two stem cell populations mostly
localized in the basal layer, i.e., Sca-1+
CD49fhi(Trop2hi) (Goldstein et al., 2008)
and Sca-1+CD133+CD44+CD117+ (Leong
et al., 2008) (Figure 1B). Yet another pop-
ulation of stem cells, termed CARNs
(for castration-resistant Nkx3.1-express-
ing cells), seems to localize exclusively
in the luminal cell layer and manifests its
stem cell properties only upon androgen
deprivation (Wang et al., 2009) (Fig-
ure 1B). The interrelationship between
the Sca-1+CD49fhi(Trop2hi) and Sca-1+
CD133+CD44+CD117+ basal stem cells
is unclear, and the phenotype of the
luminal CARNs remains to be defined.
Most important, how the stem cell proper-
ties such as self-renewal of these various
populations are regulated has not been
characterized.
In this issue of Cell Stem Cell, Lukacs
and colleagues fill this critical gap in our
knowledge and report that cells express-
ing the polycomb group protein Bmi-1
are enriched in the proximal region of the
prostate, as well as in purified Sca-1+
CD49fhi stem cells. Bmi-1 has been impli-
cated in regulating hematopoietic, neural,
and other stem cells, but its functional
roles in prostate stem cell maintenance
and prostate cancer are unknown. Using
both shRNA knockdown and overexpres-
sion approaches, the authors demon-
strate a significant functional contribution
of Bmi-1 to self-renewal andmaintenanceCell Stem Cell 7,
STEM 824_823of prostate stem cells, assessed by
in vitro serial sphere assays and in vivo
tissue regeneration using epithelial cells
recombined with urogenital sinus mesen-
chyme. Consistent with the well-known
role of Bmi-1 in regulating the Cdkn2a
locus, the authors provide evidence that
these effects on self-renewal are medi-
ated at least in part through p16 and
p19. Bmi-1 was also shown to be required
for full manifestation of increased self-
renewal initiated by constitutively active
b-catenin, suggesting that Bmi-1 may be
a mediator of Wnt/Frizzled signaling in
normal prostate stem cells. The authors
further show that Bmi-1 is required for
normal prostate tubule formation in
in vivo graft assays in SCID mice with
Bmi-1-deficient tubules displaying signs
of increased differentiation. Combined
with the results of the serial sphere
assays, these data provide convincing
evidence that Bmi-1 plays a critical role
in the self-renewal of at least some normal
prostate stem cells. Thus, Bmi-1 joins p63
(Senoo et al., 2007; Signoretti et al., 2005)
and Nkx3.1 (Wang et al., 2009) on the
short list of nuclear factors that have been
shown to regulate prostate stem cells.
An important question raised by the
study of Lukacs et al. is whether Bmi-1
regulates the self-renewal properties
of each of the reported prostate
stem cell populations discussed above
(Figure 1B). The slow-cycling LRCs
are distributed equally in both basal
and luminal layers of proximal pros-
tate tubules (Tsujimura et al., 2002);
in contrast, the Sca-1+CD49fhi(Trop2hi)
(Goldstein et al., 2008) and Scal-1+
CD133+CD44+CD117+ (Leong et al.,
2008) cells localize preferentially to theDecember 3, 2010 ª2010 Elsevier Inc. 639
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Figure 1. Mouse Prostate Lobes and Prostatic Stem Cells
(A) A macroscopic view of a dissected murine prostate lobe. Mouse prostatic
lobes consist of a branched, tree-like structure originating in the proximal
region adjacent to the urethra (U) and terminating in distal tips with a relatively
large intermediate region in between. Shown is a branched ventral prostate.
The slow-cycling LRCs are concentrated in the proximal region, as are
Bmi-1+ cells. Image courtesy of Mahipal Suraneni.
(B) A longitudinal view of a segment of prostatic duct from the proximal region.
Murine prostate ducts consist of a single layer of polarized luminal epithelium,
a discontinuous basal cell layer, and the basal lamina. Relatively rare neuroen-
docrine cells are found in the basal layer (not shown). Three stem cell popula-
tions, their phenotypes indicated in red text, have been detected in the basal or
luminal layer. The LRCs, which likely include quiescent stem cells, are distrib-
uted roughly equally in both basal and luminal cell layers (not depicted). Bmi-1+
cells appear to localize mainly in the cytokeratin 5+ basal cell layer, and Bmi-1
mRNA is enriched in the Sca-1+CD49fhi basal stem cells.
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Previewsbasal layer, whereas CARNs
seem to exist exclusively
in the luminal layer (Wang
et al., 2009). It is tempting to
speculate that the LRCs
represent a large stem cell
pool that encompasses all
stem cell subsets found in
both basal and luminal cell
compartments. The Bmi-1+
cells resemble the LRCs and
are also concentrated in the
proximal region (Figure 1A),
but the majority of Bmi-1+
cells appear to coexpress
the basal cell marker cytoker-
atin 5 (Lukacs et al., 2010),
suggesting that Bmi-1 may
preferentially regulate the
basally localized prostate
stem cells. Future endeavors
that seek to uncover the
detailed molecular mecha-
nisms whereby Bmi-1 modu-
lates prostate stem cell self-
renewal will likely offer sig-
nificant insight. Even more
pressing, efforts are needed
to elucidate the interrelation-
ships between the seemingly
disparate stem cell subpopu-
lations. These and other
questions might be ad-
dressed by generating new
research tools, such as pros-
tate-specific Bmi-1 knockout
or knockin reporters and
genetic models that allow
the purification of live LRCs.
Similar to its involvement in
normal stem cells, Bmi-1 has
also been implicated in regu-
lating cancer stem cells in
leukemia and several solid
tumors. Furthermore, Bmi-1
is often upregulated in pros-tate cancer. The authors’ demonstration
of Bmi-1 function in normal prostate stem
cell self-renewal suggests that Bmi-1
might also have a crucial role in the self-
renewal of transformed prostate cells
with stem cell-like properties. To investi-
gate this possibility, the authors examined
the effect of Bmi-1 depletion in an FGF10-
driven hyperplasia system. Their results
indicate that Bmi-1 is required for the
development of hyperplasia, which might
be interpretedasa formofPIN (prostate in-
traepithelial neoplasia). They also tested640 Cell Stem Cell 7, December 3, 2010 ª20the effect of Bmi-1 knockdown on Pten
null tumor grafts and found that Bmi-1
loss significantly reduced proliferation
and increased tumor cell apoptosis. While
the effect of Bmi-1 loss on specific pros-
tate tumor cell subpopulations was not
examined, these results point to a causal
role for Bmi-1 in prostate cancer initiation
and progression. The role Bmi-1 plays in
specific prostate tumor-initiating subpop-
ulations will be an important question to
address in the future, and the answer
may provide clues to the relationship10 Elsevier Inc.
STEM 824_823between normal prostate
stem cells and tumor-initiating
cells aswell as relapse and the
emergence of castration-
resistant disease. Much focus
has been placed on deter-
mining which prostate stem
cell population(s) may serve
as the cell of origin for prostate
cancer, but to date it is
unknown which, if any, of
these populations or their
transformed progeny contri-
bute to clinically relevant
phenomena, such as thera-
peutic resistance, recurrence,
and metastasis. Identifying
the cell of origin for castra-
tion-resistant prostate cancer
is an important complement
to isolating the cell of origin
for tumor development and
will be crucial to developing
therapeutics that can treat an-
drogen-independent tumors.
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